Paul B. Yu,Matthias Derwall,Kenneth D. Bloch,Rajeev Malhotra
申请号：
US15070774
公开号：
US20160263117A1
申请日:
2016.03.15
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides small molecule inhibitors of BMP signaling. These compounds may be used to reduce circulating levels of ApoB-100 or LDL. These compounds may also be used to treat or prevent acquired or congenital hypercholesterolemia or hyperlipoproteinemia； diseases, disorders, or syndromes associated with defects in lipid absorption or metabolism； or diseases, disorders, or syndromes caused by hyperlipidemia.
